Literature DB >> 3552343

IgA nephropathy in Korea: a morphological and clinical study.

H S Lee, H I Koh, H B Lee, H C Park.   

Abstract

IgA nephropathy (IgA N) is the most common type of primary glomerulonephritis (27.5%) in South Korea and leads to renal failure in a significant number of cases. To evaluate the possible prognosticators of this disease, renal biopsy material from 142 Korean patients with IgA N was studied by light-, electron- and immunofluorescent microscopy, and a clinicopathologic correlation was made. Modified classification of Meadow et al. [1972] for Henoch-Schoenlein nephritis was adopted for the histologic grading of glomerular lesions. Twenty-three biopsies (16.2%) exhibited histologic grades IV and V lesions in association with high levels of proteinuria, serum creatinine and blood pressure and a low frequency of gross hematuria when compared to the remaining 119 biopsies with histologic grades I to III lesions. Ninety-one patients were followed for one to 6.5 years (mean, 3.4 years). Seventeen patients (18.7%) had chronic renal insufficiency, of whom eleven eventually showed endstage renal failure. More than 70% of the patients with histologic grades IV and V exhibited progressive renal disease, whereas patients with grades I to III lesions had a benign course (p less than 0.0005). These results suggest that histologic grading may be the best index to predict the present state or the subsequent progression of the lesion in IgA N.

Entities:  

Mesh:

Year:  1987        PMID: 3552343

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients.

Authors:  Ahmad Baseer Kaihan; Yoshinari Yasuda; Takayuki Katsuno; Sawako Kato; Takahiro Imaizumi; Takaya Ozeki; Manabu Hishida; Takanobu Nagata; Masahiko Ando; Naotake Tsuboi; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2017-03-27       Impact factor: 2.801

2.  Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.

Authors:  Małgorzata Mizerska-Wasiak; Jadwiga Małdyk; Agnieszka Rybi-Szumińska; Anna Wasilewska; Monika Miklaszewska; Jacek Pietrzyk; Agnieszka Firszt-Adamczyk; Roman Stankiewicz; Beata Bieniaś; Małgorzata Zajączkowska; Katarzyna Gadomska-Prokop; Ryszard Grenda; Agnieszka Pukajło-Marczyk; Danuta Zwolińska; Maria Szczepańska; Agnieszka Turczyn; Maria Roszkowska-Blaim
Journal:  Pediatr Nephrol       Date:  2014-12-31       Impact factor: 3.714

3.  Overestimation of the risk of progression to end-stage renal disease in the poor prognosis' group according to the 2002 Japanese histological classification for immunoglobulin A nephropathy.

Authors:  Yoichi Miyazaki; Tetsuya Kawamura; Kensuke Joh; Hideo Okonogi; Kentaro Koike; Yasunori Utsunomiya; Makoto Ogura; Masato Matsushima; Mitsuhiro Yoshimura; Satoshi Horikoshi; Yusuke Suzuki; Akira Furusu; Takashi Yasuda; Sayuri Shirai; Takanori Shibata; Masayuki Endoh; Motoshi Hattori; Yuko Akioka; Ritsuko Katafuti; Akinori Hashiguchi; Kenjiro Kimura; Seiichi Matsuo; Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2013-08-10       Impact factor: 2.801

Review 4.  Asian leadership in chronic kidney disease.

Authors:  Gavin J Becker
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

5.  Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.

Authors:  Jae Ryung Shin; Seung Min Kim; Jung Sun Yoo; Ji Yoon Park; Seul Ki Kim; Joo Hee Cho; Kyung Hwan Jeong; Tae Won Lee; Chun Gyoo Ihm
Journal:  Korean J Intern Med       Date:  2014-04-29       Impact factor: 2.884

6.  Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients.

Authors:  Ahmad Baseer Kaihan; Yoshinari Yasuda; Takahiro Imaizumi; Koji Inagaki; Takaya Ozeki; Manabu Hishida; Takayuki Katsuno; Naotake Tsuboi; Shoichi Maruyama
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.